Acute myeloid leukemia following icotinib therapy for non-small cell lung cancer: a case report and literature review
Icotinib significantly improves survival and prognosis in patients with epidermal growth factor receptor (EGFR)-sensitive non-small cell lung cancer (NSCLC). It is generally well-tolerated, with treatment-related myeloid neoplasm (t-MN) being a rare adverse reaction. We report a case of a 75-year-old female patient wit...